Aptevo Therapeutics says warrant holders exercise for cash at USD 4.03 per share

Aptevo Therapeutics says warrant holders exercised for cash at USD 4.03 per share.

• Aptevo Therapeutics arranged cash exercise of existing warrants for 254,922 shares at USD 4.03, tied to about USD 4.5 million gross proceeds.
• The company is issuing unregistered Inducement Warrants for 1,274,610 shares at USD 4.03; these will be exercisable after stockholder approval and have a five-year term.
• A private placement is set to sell 861,708 unregistered shares at USD 4.03, or Pre-Funded Warrants for the same amount.
• The PIPE includes Common Warrants for 4,308,540 shares at USD 4.03; these will be exercisable after stockholder approval and have a five-year term.
• The company plans to file an SEC resale registration statement covering the PIPE shares, warrant shares, Pre-Funded Warrants, Inducement Warrants and Common Warrants.